Have a feature idea you'd love to see implemented? Let us know!

PAHC Phibro Animal Health PE ratio, current and historical analysis

The PE ratio for Phibro Animal Health stock stands at 51.21 as of Feb 4, 2025. This is calculated based on the current EPS of $0.43 and the stock price of $22.02 per share. A decrease of 49% has been recorded in the P/E ratio compared to the average of 100.6 of the last 4 quarters.

PAHC PE ratio history

How has PAHC's PE ratio performed in the past

Over the last ten years, the average PE ratio of Phibro Animal Health has been 29.08. The current 51.21 PE ratio is 76% above the historical average. In the past ten years, PAHC's PE ratio was at its highest in the Jun 2024 quarter at 279.5, with a price of $16.77 and an EPS of $0.06. The Jun 2016 quarter recorded the bottom point at 8.84, with a price of $18.66 and an EPS of $2.11.

Today
51.21
Average
29.08
Median
21.54
Minimum
8.84
Maximum
279.5

Phibro Animal Health PE ratio by year

Maximum annual increase: 1,552.87% in 2024

Maximum annual decrease: -64.81% in 2016

Year PE ratio PE change Price EPS
2024 279.5 1,552.87% $16.77 $0.06
2023 16.91 6.96% $13.7 $0.81
2022 15.81 -26.64% $19.13 $1.21
2021 21.55 -31.91% $28.88 $1.34
2020 31.65 34.51% $26.27 $0.83
2019 23.53 -17.73% $31.77 $1.35
2018 28.6 25.82% $46.05 $1.61
2017 22.73 157.13% $37.05 $1.63
2016 8.84 -64.81% $18.66 $2.11
2015 25.12 N/A $38.94 $1.55
2014 N/A N/A $21.95 -$0.1
2013 N/A N/A N/A $0.82
2012 N/A N/A N/A $0.23
2011 N/A N/A N/A -$0.19

Phibro Animal Health PE ratio by quarter (TTM)

Year PE ratio PE change Price EPS
Sep 2024 52.37 -81.26% $22.52 $0.43
Jun 2024 279.5 613.37% $16.77 $0.06
Mar 2024 39.18 25.18% $12.93 $0.33
Dec 2023 31.3 27.44% $11.58 $0.37
Sep 2023 24.56 45.24% $12.77 $0.52
Jun 2023 16.91 -21.64% $13.7 $0.81
Mar 2023 21.58 44.83% $15.32 $0.71
Dec 2022 14.9 28.89% $13.41 $0.9
Sep 2022 11.56 -26.88% $13.29 $1.15
Jun 2022 15.81 14.9% $19.13 $1.21
Mar 2022 13.76 -11.74% $19.95 $1.45
Dec 2021 15.59 -13.15% $20.42 $1.31
Sep 2021 17.95 -16.71% $21.54 $1.2
Jun 2021 21.55 -6.39% $28.88 $1.34
Mar 2021 23.02 29.18% $24.4 $1.06

PAHC average PE ratio chart

What is the average PE ratio of PAHC for the past years

The current PE ratio of PAHC is greater than its 3, 5 and 10-year historical averages.

3-year avg
47.4
5-year avg
36.45
10-year avg
29.08
15-year avg
N/A

PAHC PE vs peers

What is PAHC's PE ratio compared to its peers

PAHC's PE ratio is lower than its peer stock LLY, but it is greater than MRK's and ZTS's. Phibro Animal Health's current PE ratio of 51.21 is above the average of its peers, which is 38.41.

Stock name PE ratio Market cap
ADM Archer-Daniels-Midland Co 13.45 $22.73B
MRK Merck & Co Inc 18.94 $229.54B
ZTS Zoetis Inc 32.32 $77.71B
PAHC Phibro Animal Health Corp 51.21 $891.89M
LLY ELI LILLY & Co 88.92 $784.2B
ICCC Immucell Corp N/A $46.34M

Frequently asked questions

What is Phibro Animal Health's PE ratio?

PAHC stock has a price to earnings ratio of 51.21 as of Feb 4, 2025.

What is the 3-year average PE ratio for Phibro Animal Health (PAHC)?

Over the last 3 years, the average price to earnings ratio for PAHC stock is 47.4.

What is the 5-year average PE ratio for Phibro Animal Health (PAHC)?

Over the last 5 years, the average price to earnings ratio for PAHC stock is 36.45.

What is the highest PE ratio for PAHC?

In the last ten years, the Jun 2024 quarter recorded the highest quarterly PE ratio at 279.5.

How does the current PE ratio for PAHC compare to its historical average?

The current price to earnings ratio of PAHC is 76% higher than the 10-year historical average.

How is PAHC's PE ratio calculated (Phibro Animal Health PE ratio formula)?

To determine the PE ratio, divide the most recent stock price by the TTM earnings per share (EPS). As of today (Feb 4, 2025), Phibro Animal Health's stock price is $22.02. The earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $0.43. Therefore, Phibro Animal Health's P/E ratio for today is 51.21. PE RATIO(51.21) = STOCK PRICE($22.02) / TTM EPS($0.43)

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.